» Articles » PMID: 29185052

Functional Status Mediates the Association Between Peripheral Neuropathy and Health-related Quality of Life in Individuals with Diabetes

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2017 Nov 30
PMID 29185052
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To examine differences in health-related quality of life (HRQoL) between patients with and without diabetic peripheral neuropathy (DPN), and whether these differences can be explained by functional deficits.

Methods: This was a cross-sectional study of 160 patients with type 2 diabetes mellitus, 80 with DPN and 80 without. Assessments included HRQoL (health utility score derived from EQ-5D-5L), functional status measurements [muscle strength, timed up and go (TUG), five times sit-to-stand (FTSTS), functional reach, body sway velocity] and self-reported balance confidence [Activities-specific Balance Confidence (ABC) scale].

Results: Mean utility scores were 0.67 ± 0.14 and 0.77 ± 0.16 in patients with and without DPN, respectively (p < 0.001). Patients with DPN had lower great toe extensor strength (6.4 ± 1.8 vs 7.6 ± 2.8 lbs, p = 0.001), greater body sway velocity (2.40 ± 1.31 vs 1.90 ± 0.52 mm/s, p = 0.002), slower TUG (12.1 ± 4.6 vs 10.1 ± 2.3 s, p < 0.001) and FTSTS (15.8 ± 5.8 vs 13.9 ± 5.4 s, p = 0.03) scores, and lower ABC score (73.4 ± 21.3 vs 82.6 ± 16.9, p = 0.003), compared to those without DPN. On stepwise multiple regression, DPN status, FTSTS, body sway velocity, BMI, diabetes duration, pain, and gender explained 38% of HRQoL variance. Addition of ABC score into the model explained 45% of variance. Results from structural equation modelling showed that DPN had direct effects on HRQoL and indirect effects through FTSTS, body sway velocity, and ABC score, with χ  = 8.075 (p = 0.044), root mean square error of approximation = 0.103 (lower bound 0.015, upper bound 0.191), Comparative Fit Index = 0.966, Tucker-Lewis Index = 0.887, and Standardized Root Mean Square Residual = 0.053.

Conclusions: Patients with DPN have worse HRQoL compared to patients without DPN, partly mediated by functional status parameters. Effective interventions targeting functional status may be beneficial in improving HRQoL in these patients.

Citing Articles

Comparison of Tecar Therapy and Low-Level Laser Therapy Separately and Simultaneously on Clinical Symptoms and Health-Related Quality of Life in Individuals with Type 2 Diabetes: A 3-Month Follow-up Study.

Javan Amoli M, Khademi Kalantari K, Ahmadpour Emshi Z, Daryabor A, Naimi S Int J Endocrinol Metab. 2025; 22(1):e143135.

PMID: 40065850 PMC: 11892693. DOI: 10.5812/ijem-143135.


Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression.

Wang Y, Xu Y, Shan H, Pan H, Chen J, Yang J Health Qual Life Outcomes. 2024; 22(1):74.

PMID: 39244536 PMC: 11380328. DOI: 10.1186/s12955-024-02288-1.


Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes mellitus.

Perveen W, Ahsan H, Rameen Shahzad , Fayyaz S, Zaif A, Paracha M Sci Rep. 2024; 14(1):14430.

PMID: 38910161 PMC: 11194260. DOI: 10.1038/s41598-024-65495-2.


Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature.

Valentine W, Norrbacka K, Boye K Adv Ther. 2024; 41(7):2655-2681.

PMID: 38771477 PMC: 11213775. DOI: 10.1007/s12325-024-02878-x.


Health state utility values ranges across varying stages and severity of type 2 diabetes-related complications: A systematic review.

Tan M, Ong S, Mohd Tahir N, Mhd Ali A, Mustafa N PLoS One. 2024; 19(4):e0297589.

PMID: 38574169 PMC: 10994347. DOI: 10.1371/journal.pone.0297589.


References
1.
Allen M, Choi I, Kimpinski K, Doherty T, Rice C . Motor unit loss and weakness in association with diabetic neuropathy in humans. Muscle Nerve. 2013; 48(2):298-300. DOI: 10.1002/mus.23792. View

2.
Solli O, Stavem K, Kristiansen I . Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010; 8:18. PMC: 2829531. DOI: 10.1186/1477-7525-8-18. View

3.
Au Eong K, Chan E, Luo N, Wong S, Tan N, Lim T . Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population. Eye (Lond). 2012; 26(3):379-88. PMC: 3298978. DOI: 10.1038/eye.2011.218. View

4.
Morimoto A, Onda Y, Nishimura R, Sano H, Utsunomiya K, Tajima N . Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study. Diabetologia. 2013; 56(10):2171-5. DOI: 10.1007/s00125-013-3001-2. View

5.
Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43(4):817-24. DOI: 10.1212/wnl.43.4.817. View